Sequestrectomy as a treatment for drug-related osteonecrosis of the jaws (MRONJ) after installation of dental implants – Case report

Authors

DOI:

https://doi.org/10.33448/rsd-v10i12.20331

Keywords:

Osteonecrosis; Dental implants; Rehabilitation.

Abstract

Osteoporosis is a skeletal disorder that affects bone tissue density and predisposes to pathological fractures due to increased fragility. The treatment of this condition is through the use of drugs that can induce osteonecrosis of the jaws due to their interference in osteoclastogenesis, sometimes with exposure and sequestration of this necrotic bone. Thus, the objective of this work is a case report of a 63-year-old patient, who was being treated for osteoporosis with alendronate sodium for approximately 10 years, who presented loss of dental implants due to the occurrence of osteonecrosis of the jaws, the which was discovered after attempted rehabilitation. The patient underwent removal of implants, curettage of bone sequestration and removal of friable soft tissue. After 60 days, she presented with closed and normal colored mucosa, with no exposure of bone tissue and pain. This evidences that sequestrectomy can be used to effectively treat MRONJ and shows the importance of recognizing the factors related to the development of this alteration in bone metabolism and its implications for carrying out rehabilitative therapies. However, it is imperative that professionals be aware of possible changes in the bone tissue and soft tissue covering, considering the long half-life of these drugs.

References

Aghaloo, T., Hazboun, R., & Tetradis, S. (2015). Pathophysiology of osteonecrosis of the jaws. Oral and Maxillofacial Surgery Clinics, 27(4), 489-496.

Ahrenbog, G., Gottsauner, M., Meier, J. K., Ettl, T., Reichert, T. E., & Klingelhöffer, C. (2020). Surgical treatment of advanced medication-related osteonecrosis of the jaws: Comparison of soft tissue closure techniques and evaluation of side effects. Journal of Cranio-Maxillofacial Surgery, 48(9), 896-901.

Aljohani, S., Fliefel, R., Ihbe, J., Kühnisch, J., Ehrenfeld, M., & Otto, S. (2017). What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review. Journal of Cranio-Maxillofacial Surgery, 45(9), 1493-1502.

de-Freitas, N.-R., Lima, L.-B., de-Moura, M.-B., Veloso-Guedes, C.-d.-C.-F., Simamoto-Júnior, P.-C., & de-Magalhães, D. (2016). Bisphosphonate treatment and dental implants: A systematic review. Med Oral Patol Oral Cir Bucal, 21(5), e644.

Dimopoulos, M., Kastritis, E., Bamia, C., Melakopoulos, I., Gika, D., Roussou, M., . . . Terpos, E. (2009). Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Annals of Oncology, 20(1), 117-120.

Ervolino, E., Statkievicz, C., Toro, L. F., de Mello-Neto, J. M., Cavazana, T. P., Issa, J. P. M., . . . Okamoto, R. (2019). Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone, 120, 101-113.

Mendes, V., Dos Santos, G., Calasans-Maia, M., Granjeiro, J., & Moraschini, V. (2019). Impact of bisphosphonate therapy on dental implant outcomes: An overview of systematic review evidence. International journal of oral and maxillofacial surgery, 48(3), 373-381.

Papadakis, I., Spanou, A., & Kalyvas, D. (2021). Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review. Journal of Oral Implantology, 47(2), 169-180.

Qamheya, A. H. A., Yeniyol, S., & Arisan, V. (2016). Bisphosphonate-related osteonecrosis of the jaw and dental implants. Journal of Istanbul University Faculty of Dentistry, 50(1), 59.

Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. Journal of oral and maxillofacial surgery, 72(10), 1938-1956.

Statkievicz, C., Toro, L. F., de Mello-Neto, J. M., de Sá, D. P., Casatti, C. A., Issa, J. P. M., . . . Garcia, V. G. (2018). Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats. Journal of Photochemistry and Photobiology B: Biology, 184, 7-17.

Storelli, S., Palandrani, G., Dondi, C., Tagliatesta, L., & Rossi, A. (2019). Severe case of osteonecrosis following implant placement in a patient in therapy with bisphosphonates: A case report. Journal of Oral Implantology, 45(2), 139-144.

Tallarico, M., Canullo, L., Xhanari, E., & Meloni, S. M. (2016). Dental implants treatment outcomes in patient under active therapy with alendronate: 3‐year follow‐up results of a multicenter prospective observational study. Clinical oral implants research, 27(8), 943-949.

Wehrhan, F., Weber, M., Neukam, F. W., Geppert, C.-I., Kesting, M., & Preidl, R. H. (2019). Fluorescence-guided bone resection: a histological analysis in medication-related osteonecrosis of the jaw. Journal of Cranio-Maxillofacial Surgery, 47(10), 1600-1607.

Published

24/09/2021

How to Cite

SILVA, M. C.; PAVELSKI , M. D. .; DELANORA, L. A.; LIMA NETO, T. J. de .; SANTOS, A. M. de S.; BARBOSA, S.; SANTOS, J. M. F. e; FERREIRA, J. P.; PASTORI, C. M. .; SALIBA, M. T. A.; FURUSE, C.; FAVERANI, L. P. Sequestrectomy as a treatment for drug-related osteonecrosis of the jaws (MRONJ) after installation of dental implants – Case report. Research, Society and Development, [S. l.], v. 10, n. 12, p. e362101220331, 2021. DOI: 10.33448/rsd-v10i12.20331. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/20331. Acesso em: 23 apr. 2024.

Issue

Section

Health Sciences